Clinical Trial: A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777549) titled 'A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)' on Aug. 17.

Brief Summary: This study will consist of two parts. Double blind Part A will assess the safety, tolerability, and pharmacokinetics of 7 days of dosing in healthy adults, while open label Part B will evaluate the safety, tolerability, and efficacy of a 2-week treatment course in adults with tinnitus.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Tinnitus

Intervention: DRUG: TRTL-913

Participants will receive TRTL-913 capsules QD.

DRUG: Placebo

Participants will receive TRTL-91...